# Microbiological Data for Systemic Antibacterial Drug Products — Development, Analysis, and Presentation - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/microbiological-data-for-systemic-antibacterial-drug-products-development-analysis-and-presentation/7dedd6ea-e14b-4895-8669-b06331204496

> FDA guidance document: Microbiological Data for Systemic Antibacterial Drug Products — Development, Analysis, and Presentation. Issue date: February 07, 2018. Get complete insights and analysis.

---

## Details

- Title: Microbiological Data for Systemic Antibacterial Drug Products — Development, Analysis, and Presentation
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-02-07
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2009-D-0408">FDA-2009-D-0408</a>

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Human Immunodeficiency Virus-1 Infection:  Developing Systemic Drug Products for Pre-Exposure Prophylaxis](https://www.globalkeysolutions.net/guidances/guidance-document/human-immunodeficiency-virus-1-infection-developing-systemic-drug-products-for-pre-exposure-prophylaxis/954b4104-b554-475b-90aa-d413f78e97c8)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)